Literature DB >> 22710982

Myofibroblasts in interstitial lung diseases show diverse electron microscopic and invasive features.

Henna M Karvonen1, Siri T Lehtonen, Raija T Sormunen, Terttu H Harju, Elisa Lappi-Blanco, Risto S Bloigu, Riitta L Kaarteenaho.   

Abstract

The characteristic features of myofibroblasts in various lung disorders are poorly understood. We have evaluated the ultrastructure and invasive capacities of myofibroblasts cultured from small volumes of diagnostic bronchoalveolar lavage (BAL) fluid samples from patients with different types of lung diseases. Cells were cultured from samples of BAL fluid collected from 51 patients that had undergone bronchoscopy and BAL for diagnostic purposes. The cells were visualized by transmission electron microscopy and immunoelectron microscopy to achieve ultrastructural localization of alpha-smooth muscle actin (α-SMA) and fibronectin. The levels of α-SMA protein and mRNA and fibronectin mRNA were measured by western blot and quantitative real-time reverse transcriptase polymerase chain reaction. The invasive capacities of the cells were evaluated. The cultured cells were either fibroblasts or myofibroblasts. The structure of the fibronexus, and the amounts of intracellular actin, extracellular fibronectin and cell junctions of myofibroblasts varied in different diseases. In electron and immunoelectron microscopy, cells cultured from interstitial lung diseases (ILDs) expressed more actin filaments and α-SMA than normal lung. The invasive capacity of the cells obtained from patients with idiopathic pulmonary fibrosis was higher than that from patients with other type of ILDs. Cells expressing more actin filaments had a higher invasion capacity. It is concluded that electron and immunoelectron microscopic studies of myofibroblasts can reveal differential features in various diseases. An analysis of myofibroblasts cultured from diagnostic BAL fluid samples may represent a new kind of tool for diagnostics and research into lung diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710982     DOI: 10.1038/labinvest.2012.95

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

1.  Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion.

Authors:  Neil Ahluwalia; Paula E Grasberger; Brian M Mugo; Carol Feghali-Bostwick; Annie Pardo; Moisés Selman; David Lagares; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

2.  3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs.

Authors:  Ranu Surolia; Fu Jun Li; Zheng Wang; Huashi Li; Gang Liu; Yong Zhou; Tracy Luckhardt; Sejong Bae; Rui-Ming Liu; Sunad Rangarajan; Joao de Andrade; Victor J Thannickal; Veena B Antony
Journal:  JCI Insight       Date:  2017-01-26

3.  Effect of Qingfei Mixture () on pediatric mycoplasma pneumoniae pneumonia with phlegm heat obstructing Fei (Lung) syndrome.

Authors:  Ai-Jun Yang; Kun Xi; Yan-Qing Yao; Ying-Xue Ding; Li-Jun Yang; Hong Cui
Journal:  Chin J Integr Med       Date:  2017-09-02       Impact factor: 1.978

4.  Dermal Fibroblasts from the Red Duroc Pig Have an Inherently Fibrogenic Phenotype: An In Vitro Model of Fibroproliferative Scarring.

Authors:  Ravi F Sood; Lara A Muffley; Max E Seaton; Maricar Ga; Pornthep Sirimahachaiyakul; Anne M Hocking; Nicole S Gibran
Journal:  Plast Reconstr Surg       Date:  2015-11       Impact factor: 4.730

5.  Pathologic Proteolytic Processing of N-Cadherin as a Marker of Human Fibrotic Disease.

Authors:  Paul Durham Ferrell; Kristianne Michelle Oristian; Everett Cockrell; Salvatore Vincent Pizzo
Journal:  Cells       Date:  2022-01-04       Impact factor: 6.600

6.  NHLRC2 expression is increased in idiopathic pulmonary fibrosis.

Authors:  Mervi Kreus; Siri Lehtonen; Reetta Hinttala; Johanna Salonen; Katja Porvari; Riitta Kaarteenaho
Journal:  Respir Res       Date:  2022-08-13

Review 7.  The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis.

Authors:  Riitta Kaarteenaho
Journal:  Respir Res       Date:  2013-04-15

8.  Myofibroblast expression in airways and alveoli is affected by smoking and COPD.

Authors:  Henna M Karvonen; Siri T Lehtonen; Terttu Harju; Raija T Sormunen; Elisa Lappi-Blanco; Johanna M Mäkinen; Kirsi Laitakari; Shirley Johnson; Riitta L Kaarteenaho
Journal:  Respir Res       Date:  2013-08-11

9.  Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis.

Authors:  Siri T Lehtonen; Anniina Veijola; Henna Karvonen; Elisa Lappi-Blanco; Raija Sormunen; Saara Korpela; Ulrika Zagai; Magnus C Sköld; Riitta Kaarteenaho
Journal:  Respir Res       Date:  2016-02-04

10.  Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis.

Authors:  Yating Wang; Miaoqing Lu; Liping Xiong; Jinjin Fan; Yi Zhou; Huiyan Li; Xuan Peng; Zhong Zhong; Yihan Wang; Fengxian Huang; Wei Chen; Xueqing Yu; Haiping Mao
Journal:  Cell Death Dis       Date:  2020-01-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.